Search company, investor...

Founded Year

2004

Stage

Acquired | Acquired

Valuation

$0000 

About Vandalia Research

Vandalia Research, founded in 2004, is a life sciences research company. The company places strong emphasis on research and development directed to specific market needs, with the objective of commercializing novel biotechnology instrumentation and advanced biotechnology manufacturing techniques. Vandalia is developing tools, such as Triathlon, to be competitive in a large marketplace. Vandalia will use these tools to market DNA products and services to commercial, educational, and other research facilities. In addition, Vandalia is seeking strategic partnerships to broaden the use of novel instrumentation and manufacturing techniques.

Headquarters Location

1111 Veterans Memorial Blvd.

Huntingtown, West Virginia, 25701,

United States

304-529-0803

Loading...

Loading...

Vandalia Research Patents

Vandalia Research has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/6/2009

4/24/2012

Molecular biology, Polymerase chain reaction, Chemical reactions, DNA, Molecular biology techniques

Grant

Application Date

4/6/2009

Grant Date

4/24/2012

Title

Related Topics

Molecular biology, Polymerase chain reaction, Chemical reactions, DNA, Molecular biology techniques

Status

Grant

Latest Vandalia Research News

Applied DNA Sciences Enters Diagnostics Market With New DNA Orders

Nov 2, 2015

STONY BROOK, NY--(Marketwired - November 02, 2015) - Applied DNA Sciences, Inc. (NASDAQ: APDN ) (Twitter: @APDN), a Provider of DNA-based anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced that it has shipped its first orders of DNA used as a diagnostic reagent to reagent suppliers and two international diagnostics customers. The total value of these shipments, which were made in its fiscal 2015 fourth quarter and the current fiscal first quarter, is over $400,000. On September 11, 2015, APDN announce the acquisition of Vandalia Research, Inc., whose core technology and intellectual property portfolio allows for the large-scale production of specific DNA sequences using polymerase chain reaction (PCR). As part of the acquisition, Applied DNA assumed Vandalia's backlog of orders. Dr. James Hayward, CEO of Applied DNA Sciences, stated: "With the fulfillment of these orders, we are already beginning to reap the benefits of the acquisition. Whereas Vandalia's PCR technology enhances our in-house DNA manufacturing capacity as demand drivers strengthen across key business verticals, it simultaneously provides us entrée into biotechnology, pharmaceutical and diagnostic markets. As we continue to provide contract production of DNA to clients in these markets, we plan to also introduce them to our DNA-based security solutions to protect their products against theft of their IP and the invasion of counterfeits into their supply chains. " DNA production by PCR is not a broadly available commercial service, especially at large scale. The advantage of PCR-based production is the purity of product compared to the DNA produced by the more commonly available fermentation methods. DNA-based diagnostic reagents may be used in the early detection of cancer, or the diagnosis of genetic, metabolic or infectious diseases. DNA-based therapeutics may be used in gene therapies, DNA vaccines, and other therapies that are generally in the early stage of development. By providing the production of DNA for diagnostics and therapeutics, APDN expects to gain access to pharmaceutic customers who will likely have supply chain concerns, and need to protect themselves against the potential of counterfeit infiltration and comply with FDA efforts to eliminate counterfeits. "Double-stranded DNA is fundamental to the biotechnology, pharmaceutical and diagnostics markets and we believe our capacity to manufacture it by PCR is unsurpassed in the world," concluded Dr. Hayward. "Unlike "synthetic DNA," which is single-stranded, double-stranded DNA provides more informational content and is less subject to degradation, which can lead to an inability to authenticate when the need is critical. Much of our patent portfolio addresses the stability of our double-stranded DNA markers, which, when supplemented by Vandalia's enhancements to our manufacturing capabilities, delivers cutting-edge value, purity of product and capacity to manufacture to the demanding specifications these markets require. With leadership positions in double-stranded DNA and its manufacture, we believe we are well positioned to succeed in these markets. " About Applied DNA Sciences Applied DNA Sciences makes life real and safe by providing biotechnology-driven solutions to help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Patented botanical DNA solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature DNA is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. Forward Looking Statements The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11,2015 and August 10, 2015, which are available at www.sec.gov . APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law. Source: Marketwired - All

Vandalia Research Frequently Asked Questions (FAQ)

  • When was Vandalia Research founded?

    Vandalia Research was founded in 2004.

  • Where is Vandalia Research's headquarters?

    Vandalia Research's headquarters is located at 1111 Veterans Memorial Blvd., Huntingtown.

  • What is Vandalia Research's latest funding round?

    Vandalia Research's latest funding round is Acquired.

  • Who are the investors of Vandalia Research?

    Investors of Vandalia Research include Applied DNA Sciences, West Virginia Jobs Investment Trust and Mountaineer Capital.

  • Who are Vandalia Research's competitors?

    Competitors of Vandalia Research include AmideBio, Axxam, Bridge to Life, Bloomage BioTech, Akron Biotechnology and 7 more.

Loading...

Compare Vandalia Research to Competitors

Oceanit Logo
Oceanit

Oceanit is a 'Mind to Market' company that focuses on creating disruptive technology from fundamental science across various sectors such as aerospace, healthcare, energy, and industrial/consumer technologies. The company offers a range of services including engineering consulting, information systems consulting, and management consulting, with a focus on creating innovative solutions through scientific research and design thinking. Oceanit primarily serves sectors such as the energy industry, healthcare sector, aerospace and defense industry, and the industrial and consumer technology industry. It was founded in 2002 and is based in Honolulu, Hawaii.

T
Tethis Srl

Tethis Srl focuses on standardizing liquid biopsy for oncology diagnostics within the healthcare sector. The company offers a proprietary technology for immediate, fully automated, and gentle processing of blood samples, which is essential for maintaining sample integrity and clinical informativity. Tethis Srl's technology is designed to support high throughput analytical protocols for sensitive and specific blood-based cancer testing across various clinical settings. It was founded in 2004 and is based in Italy.

I
Intas Biopharmaceuticals

Intas Biopharmaceuticals Limited is a biopharmaceutical company based out of Ahmedabad, Gujarat, India. Since launch of biotechnology operations in May 2000, Research & Development (R&D) and Manufacturing of Biopharmaceutical products with a special focus on Oncology (Cancer) are the major thrust areas for the company.nIntas Biopharmaceuticals is India's first and only biopharmaceuticals company to receive European Union -Good Manufacturing Practice (EU-GMP) certification for its manufacturing facility.

L
Laureate Pharma

Laureate Pharma is a company focused on the healthcare and pharmaceutical industry. It provides a range of services including the synthesis of pharmaceutical substances, the creation of finished dosage forms, and the development and launch of pulmonary drugs. The company primarily sells to the healthcare sector, with a focus on pharmacies and other pharmaceutical companies. It is based in Princeton, New Jersey.

Blaze Systems Logo
Blaze Systems

Blaze Systems specializes in laboratory information management systems (LIMS) within the software industry. The company offers a comprehensive suite of LIMS solutions designed to automate laboratory operations, manage resources, and ensure regulatory compliance. Blaze Systems primarily serves sectors such as biotechnology, clinical labs, manufacturing, and pharmaceuticals. It was founded in 1991 and is based in Newark, Delaware.

Plexus Ventures Logo
Plexus Ventures

Plexus Ventures is a healthcare advisory boutique operating in the healthcare, pharma, medical devices, biotech, and consumer health sectors. The company offers strategic advisory services, managing long and time-consuming transactions, and provides structure to corporate and business development activities. Primarily, Plexus Ventures caters to healthcare companies of all sizes worldwide. It is based in Santa Monica, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.